Literature DB >> 20693555

A clinicopathological correlation of 67 eyes primarily enucleated for advanced intraocular retinoblastoma.

Matthew W Wilson1, Ibrahim Qaddoumi, Catherine Billups, Barrett G Haik, Carlos Rodriguez-Galindo.   

Abstract

AIMS: To correlate the clinical and histopathological findings of eyes primarily enucleated for advanced intraocular retinoblastoma.
METHODS: In a retrospective study, the authors identified patients primarily enucleated for advanced intraocular retinoblastoma. The authors retrieved patient demographics, clinical findings, subsequent treatments and outcomes, and reviewed the histopathology of each eye for invasion of the anterior chamber, iris, ciliary body, choroid, sclera and optic nerve, and extraocular extension. The authors used the Fisher exact, exact Jonkheere-Terpstra, exact Wilcoxon rank sum and Kruskal-Wallis statistical tests (p<0.05) to study associations between clinical and histopathological findings.
RESULTS: The authors identified 67 eyes of 67 patients (33 males) primarily enucleated for retinoblastoma between March 1997 and January 2008. Corneal diameter, intraocular pressure and Reese-Ellsworth Classification had no significant association with invasive disease. The International Classification, however, was associated with optic nerve (p=0.026), choroid (p<0.001), ciliary body (p=0.002), iris (p=0.002), anterior chamber (p=0.025) and scleral (p<0.001) invasion. Eyes classified as International Classification Group E were more likely to have invasion of these sites and have more severe optic-nerve invasion.
CONCLUSIONS: Corneal diameter, intraocular pressure and Reese-Ellsworth Classification do not correlate with histopathological evidence of invasive retinoblastoma. Eyes classified as International Classification Group E are more likely to have elevated intraocular pressure, invasion of the anterior chamber, uveal tract, optic nerve and sclera. The findings warrant primary enucleation with meticulous histopathological examination of such eyes prior to any adjuvant therapy.

Entities:  

Mesh:

Year:  2010        PMID: 20693555     DOI: 10.1136/bjo.2009.177444

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  24 in total

1.  Comparison of high-risk histopathological features in eyes with primary or secondary enucleation for retinoblastoma.

Authors:  Rachel C Brennan; Ibrahim Qaddoumi; Catherine A Billups; Tammy L Free; Barrett G Haik; Carlos Rodriguez-Galindo; Matthew W Wilson
Journal:  Br J Ophthalmol       Date:  2015-04-14       Impact factor: 4.638

2.  Pathological findings in enucleated eyes after intravitreal melphalan injection.

Authors:  Fariba Ghassemi; Fahimeh Asadi Amoli
Journal:  Int Ophthalmol       Date:  2013-09-17       Impact factor: 2.031

3.  Retinoblastoma. Fifty years of progress. The LXXI Edward Jackson Memorial Lecture.

Authors:  Hans E Grossniklaus
Journal:  Am J Ophthalmol       Date:  2014-07-24       Impact factor: 5.258

4.  High-resolution MRI using orbit surface coils for the evaluation of metastatic risk factors in 143 children with retinoblastoma: Part 1: MRI vs. histopathology.

Authors:  Selma Sirin; Marc Schlamann; Klaus A Metz; Norbert Bornfeld; Bernd Schweiger; Markus Holdt; Petra Temming; Michael M Schuendeln; Sophia L Goericke
Journal:  Neuroradiology       Date:  2015-06-04       Impact factor: 2.804

5.  Selective ophthalmic arterial injection of melphalan for intraocular retinoblastoma: a 4-year review.

Authors:  Sherine Jue Ong; An-Ning Chao; Ho-Fai Wong; Kuan-Lyin Liou; Ling-Yuh Kao
Journal:  Jpn J Ophthalmol       Date:  2014-12-03       Impact factor: 2.447

6.  Correlation of apparent diffusion coefficient at 3T with prognostic parameters of retinoblastoma.

Authors:  A A K Abdel Razek; S Elkhamary; S Al-Mesfer; H M Alkatan
Journal:  AJNR Am J Neuroradiol       Date:  2012-01-12       Impact factor: 3.825

Review 7.  Management of retinoblastoma in children: current status.

Authors:  Guillermo Chantada; Paula Schaiquevich
Journal:  Paediatr Drugs       Date:  2015-06       Impact factor: 3.022

8.  Correlation between conventional MR imaging combined with diffusion-weighted imaging and histopathologic findings in eyes primarily enucleated for advanced retinoblastoma: a retrospective study.

Authors:  Yanfen Cui; Ran Luo; Ruifen Wang; Huanhuan Liu; Caiyuan Zhang; Zhongyang Zhang; Dengbin Wang
Journal:  Eur Radiol       Date:  2017-08-07       Impact factor: 5.315

9.  Retinoblastoma major review with updates on Middle East management protocols.

Authors:  Ihab Saad Othman
Journal:  Saudi J Ophthalmol       Date:  2012-04

Review 10.  Retinoblastoma.

Authors:  Helen Dimaras; Timothy W Corson; David Cobrinik; Abby White; Junyang Zhao; Francis L Munier; David H Abramson; Carol L Shields; Guillermo L Chantada; Festus Njuguna; Brenda L Gallie
Journal:  Nat Rev Dis Primers       Date:  2015-08-27       Impact factor: 52.329

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.